Fourth quarter trading update | 09-Apr-2024 | 07:00 | RNS |
Director/PDMR Dealing – Late ... | 15-Mar-2024 | 13:15 | RNS |
Director Declaration | 06-Mar-2024 | 10:00 | RNS |
Director/PDMR Shareholding | 01-Feb-2024 | 16:12 | RNS |
Director/PDMR Shareholding | 29-Jan-2024 | 16:58 | RNS |
Director/PDMR Shareholding | 15-Jan-2024 | 15:29 | RNS |
Third quarter trading update | 10-Jan-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 21-Dec-2023 | 16:45 | RNS |
Interim Results | 13-Dec-2023 | 07:00 | RNS |
Publication of B Corp Impact Report 2023 | 01-Dec-2023 | 07:00 | RNS |
Second quarter trading update | 20-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 20-Sep-2023 | 07:00 | RNS |
Result of AGM | 20-Sep-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 07-Sep-2023 | 11:26 | RNS |
CEO Appointment | 21-Aug-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 25.10p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 33.80p |
52 Week Low | 18.25p |
Volume | 0 |
Shares Issued | 108.96m |
Market Cap | £27.35m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
Final | ||
Ex-Div | 01-Sep-22 | |
Paid | 30-Sep-22 | |
Amount | 0.90p |
CFO | Daniel (Dan) Walden |
CEO | Lee Tappenden |
You are here: research